Literature DB >> 15867284

Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults.

Kirsten F Hilpert1, Penny M Kris-Etherton, Sheila G West.   

Abstract

Recent evidence suggests that individuals with high concentrations of C-reactive protein (CRP), a marker of inflammation, are less responsive to cholesterol-lowering diets. CRP concentrations are increased by oral estrogen; however, the effect of soy phytoestrogens on inflammation has not been studied comprehensively, especially in women receiving hormone replacement therapy (HRT). This study was conducted to determine whether adding soy to a low-fat, high-fiber diet affects CRP and interleukin (IL)-6, and to examine the association between CRP levels and lipid response in moderately hypercholesterolemic adults (men = 18, postmenopausal women = 14; 6 receiving HRT). After a 3-wk run-in period with consumption of a Step I diet (27% total fat, 7% saturated fat, 275 mg cholesterol), participants were randomly assigned to diets containing 25 g/d soy protein (+ 90 mg/d isoflavones) or 25 g/d milk protein for 6 wk in a crossover design. Lipids and lipoproteins, CRP, and IL-6 were measured at the end of each diet and participants were categorized into high (>3.5 mg/L) or low CRP groups based on a median split. The addition of soy or milk protein to the Step I diet did not affect lipids or inflammatory markers. Regardless of protein source, those with low CRP exhibited significant decreases in LDL cholesterol (-3.5%) and the LDL:HDL cholesterol ratio (-4.8%), whereas those with high CRP had significant increases in LDL cholesterol (+4.8%), the LDL:HDL cholesterol ratio (+5.2%), apolipoprotein B (+3.8%), and lipoprotein(a) (+13.5%) compared with the run-in diet. These results suggest that inflammation may not only attenuate lipid responses, but also aggravate dyslipidemia in hypercholesterolemic subjects consuming a cholesterol-lowering diet.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15867284     DOI: 10.1093/jn/135.5.1075

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  8 in total

Review 1.  Effects of adiposity on plasma lipid response to reductions in dietary saturated fatty acids and cholesterol.

Authors:  Michael R Flock; Michael H Green; Penny M Kris-Etherton
Journal:  Adv Nutr       Date:  2011-04-30       Impact factor: 8.701

Review 2.  Effects of soy intake on circulating levels of TNF-α and interleukin-6: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Mahdieh Khodarahmi; Elaheh Foroumandi; Mohammad Asghari Jafarabadi
Journal:  Eur J Nutr       Date:  2021-01-05       Impact factor: 5.614

3.  Baseline serum C-reactive protein is associated with lipid responses to low-fat and high-polyunsaturated fat diets.

Authors:  Marie-Pierre St-Onge; Sijian Zhang; Betty Darnell; David B Allison
Journal:  J Nutr       Date:  2009-04       Impact factor: 4.798

4.  Baseline inflammatory markers do not modulate the lipid response to weight loss.

Authors:  Marie-Pierre St-Onge; Renee Desmond; Gary Hunter; Barbara Gower
Journal:  Metabolism       Date:  2008-05       Impact factor: 8.694

5.  Associations between urinary soy isoflavonoids and two inflammatory markers in adults in the United States in 2005-2008.

Authors:  Holly L Nicastro; Alison M Mondul; Sabine Rohrmann; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2013-04-05       Impact factor: 2.506

6.  Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins.

Authors:  Michael A Roussell; Alison M Hill; Trent L Gaugler; Sheila G West; John P Vanden Heuvel; Petar Alaupovic; Peter J Gillies; Penny M Kris-Etherton
Journal:  Am J Clin Nutr       Date:  2011-12-14       Impact factor: 7.045

7.  Serum adiponectin level and different kinds of cancer: a review of recent evidence.

Authors:  Vajihe Izadi; Elaheh Farabad; Leila Azadbakht
Journal:  ISRN Oncol       Date:  2012-11-18

8.  Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease.

Authors:  Elizabeth A Droke; Brenda J Smith; Kelly A Hager; Megan R Lerner; Stan A Lightfoot; Barbara J Stoecker; Daniel J Brackett
Journal:  J Inflamm (Lond)       Date:  2007-09-07       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.